Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
26
NCT01339481
A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept
Phase: N/A
Role: Collaborator
Start: Feb 28, 2011
Completion: Oct 31, 2011